Clin2
NCT05830279Possibly a fitRecruiting

Personalized drug choices to better manage cancer treatment side effects

Nausea With Vomiting Chemotherapy-InducedDepression, ReactiveCancer Pain

Part of Mental health, Pain clinical trials.

This trial tests a personalized approach to selecting drugs during cancer treatment. The goal is to improve how well your prescribed medicines work for symptoms and side effects while keeping you safe.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
600 people
Ages
18 years and older
Study type
Observational

Who can take part

  • Be 18 years or older
  • Be prescribed chemotherapy
  • Currently take at least one of these study medicines: citalopram, escitalopram, venlafaxine, desvenlafaxine, codeine, oxycodone, hydrocodone, tramadol, or ondansetron
  • Be able to complete study surveys (with or without help), including in the required language(s)
  • Not be receiving palliative (comfort-focused) care

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07365007Recruiting
Diet study to improve nerve pain after chemo

This study tests a diet program delivered online to help reduce nerve damage symptoms like numbness and tingling caused by chemotherapy. It is for cancer survivors who completed treatment and still have these symptoms.

Ann Arbor, Michigan
NCT07455955Recruiting· Phase 2
Custom anti-nausea treatment based on your genes

This trial tests if giving anti-nausea drugs based on your genetic makeup can better prevent vomiting and nausea from chemotherapy for early breast cancer. You will receive a personalized regimen tailored to your pharmacogenetic profile.

Hong Kong
NCT05166694Recruiting
Personalized testing to check drug interactions and gene effects

This study uses personalized information to help understand how your current medicines interact with each other and with your genes. It may help your care team choose safer, more effective medication plans for you.

Chicago, Illinois
NCT07480486Not yet recruiting
Personalized antidepressant selection using genetic testing

This study tests whether using a genetic test can help doctors choose the most effective antidepressant for people with depression. The goal is to improve treatment outcomes and reduce side effects by tailoring the medication to your genetic makeup.

Rabat, Rabat-Salé-Kénitra
NCT07343024Recruiting
Finding a Personalized Drug for Advanced Cancer

This trial looks at whether drugs not usually used for your type of cancer can help you. It matches your tumor's test results to possible treatments and works with your doctor to try one.

Palo Alto, California
NCT07796295Not yet recruiting
Personalised antidepressant choice using genetics

This trial tests whether using a website plus your genetic information helps doctors pick a better antidepressant for you. It aims to improve treatment for people with depression.

Addis Ababa

Hear when a new Cancer Pain trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.